Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 2 months ago

Possible Interaction: Fatty Acids, Omega-3 and Antipsychotic Agents

Research Papers that Mention the Interaction

In patients with first-episode schizophrenia, omega-3 decreased nonpsychotic symptoms, required lower antipsychotic medication dosages, and improved early treatment response rates.
Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists  •  2015  |  View Paper
CONCLUSION we found that supplemental omega-3 might increase efficacy of conventional antipsychotics in decreasing symptoms of schizophrenia.
CONCLUSION we found that supplemental omega-3 might increase efficacy of conventional antipsychotics in decreasing symptoms of schizophrenia.
Global journal of health science  •  2014  |  View Paper
In accordance to the above mentioned findings, as omega-3 fatty acids per se have a direct cardiovascular protective role, our paper hypothesized that omega-3 fatty acids supplementation in ASD patients treated with atypical antipsychotic drugs may reduce cardiac arrhythmias and hence sudden cardiac death.
Arquivos de neuro-psiquiatria  •  2009  |  View Paper
The administration of antipsychotics and n-3 fatty acids act on different points in this etiological cascade.
Nihon shinkei seishin yakurigaku zasshi = Japanese journal of psychopharmacology  •  2006  |  View Paper
CONCLUSIONS The application of omega-3 fatty acids has antipsychotic effects and causes an oxidative imbalance.
The American journal of the medical sciences  •  2015  |  View Paper
Emerging evidence suggests that SGAs and LCn-3 fatty acids have opposing effects on stearoyl-CoA desaturase-1 (SCD1), which plays a pivotal role in TAG biosynthesis.
Pharmacological research  •  2012  |  View Paper